Erika Hamilton Md

Dr. Erika Hamilton on Scripps News

Sarah Cannon Research Institute

Erika Hamilton, MD | When to Use CDK 4/6 Inhibitors

Total Health | Oncology

Erika Hamilton, MD, on the standard of care for high-risk early HR+, HER2- breast cancer

Erika Hamilton, MD, considers the role of NGS testing for breast cancer patients

Dr. Erika Hamilton Discusses How Women Can Be Proactive About Their Breast Health – NBCLX

Sarah Cannon Research Institute

Dr. Erika Hamilton on Late Stage Breast Cancer on LX News - NBCLX

Sarah Cannon Research Institute

Erika Hamilton, MD, provides perspective on the latest immunotherapy treatment trends in TNBC

Erika Hamilton, MD, regarding the use of CDK 4/6 inhibitors in clinical practice

Erika Hamilton, MD, considers the significance of the monarchE study & the use of abemaciclib

Erika Hamilton, MD, shares thoughts on tolerability in high risk early breast cancer patients

Erika Hamilton, MD, considers the comparison between the monarchE and PALLAS clinical trials

Opportunities in ER+/HER2- Breast Cancer Care - Erika P. Hamilton, MD

Clinical Care Options

Dr. Erika Hamilton On The Importance Of Screenings And Protocols To Ensure Patients’ Safety – CBSN

Sarah Cannon Research Institute

Erika Hamilton, MD, discusses findings from the MARIO-3 clinical trial presented at the 2020 SABCS

Erika Hamilton, MD, on how CDK4/6 inhibitors transformed the management of metastatic breast cancer

Dr. Erika P. Hamilton on The Shifting Treatment Paradigm in HER2-Positive Breast Cancer

Targeted Oncology

Dr. Erika Hamilton Explains Breast Cancer Breakthrough on Michaela, Headline News, CNN

Sarah Cannon Research Institute

Dr. Erika P. Hamilton on ONT-380 in HER2-Positive Breast Cancer Patients With Brain Metastases

Targeted Oncology

The importance of scheduling mammograms, even amid the pandemic

Dr. Erika Hamilton Shares an Important Breast Cancer Research Update - Newsy

Sarah Cannon Research Institute